El-Rayadh Fertility Centre Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2014
NCT02041910
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

El-Rayadh Fertility Center | Hesham Saeed Elshaer

Active Ingredients

Drugs in Phase 2 Trials (2)

bone marrow derived mesenchymal stem cells (1 trial)

stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Azoospermia (Phase 2)

Menopause, Premature (Phase 2)

Premature Birth (Phase 2)

Primary Ovarian Insufficiency (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2